HARVARD BIOSCIENCE INC (HBIO) › Cost of RevenueHARVARD BIOSCIENCE INC (HBIO) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2009: $44.09M2010: $56.37M2011: $58.67M2012: $58.83M2013: $57.48M2014: $59.32M2015: $59.94M2016: $56.11M2017: $38.24M2018: $57.59M2019: $51.85M2020: $44.06M2021: $51.25M2022: $52.52M2023: $46.18M2024: $39.37M2025: $36.64M$36.64M2009Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$36.64M-6.9%2024$39.37M-14.7%2023$46.18M-12.1%2022$52.52M+2.5%2021$51.25M+16.3%2020$44.06M-15.0%2019$51.85M-10.0%2018$57.59M+50.6%2017$38.24M-31.8%2016$56.11M-6.4%2015$59.94M+1.0%2014$59.32M+3.2%2013$57.48M-2.3%2012$58.83M+0.3%2011$58.67M+4.1%2010$56.37M+27.9%2009$44.09M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share